ArticleBritish journal of cancer2013

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours.

A Adenis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.